A man in a blue shirt signing a document
A man in a blue shirt signing a document

Financial Information

Take a closer look at our Financial Guidance 2023 and the Fundamentals of MorphoSys.

MORPHOSYS 2022 ANNUAL REPORT

Teaser Annual Report 2022
Annual Report 2022

Reports

  • Consolidated Financial Statements (IFRS) 2010 |
  • Annual Report 2010 |
  • Financial Statements 2010 of MorphoSys AG (German GAAP - HGB) |
  • Nine Months' Report 2010 |
  • Six Months' Report 2010 |
  • Three Months’ Report 2010 |

Financial Guidance 2024

As a consequence of the sale and transfer of tafasitamab to Incyte, MorphoSys' 2024 financial guidance published on January 30, 2024 cannot be maintained. MorphoSys will publish a new financial guidance in due course.